Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xeris Biopharma Holdings (XERS) Non Operating Income (2020 - 2026)

Xeris Biopharma Holdings filings provide 6 years of Non Operating Income readings, the most recent being -$5.7 million for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 16.2% to -$5.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$24.3 million, a 3.77% decrease, with the full-year FY2025 number at -$24.3 million, down 3.77% from a year prior.
  • Non Operating Income hit -$5.7 million in Q4 2025 for Xeris Biopharma Holdings, up from -$6.1 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.9 million in Q4 2022 to a low of -$7.6 million in Q3 2023.
  • Median Non Operating Income over the past 5 years was -$4.8 million (2022), compared with a mean of -$4.5 million.
  • The widest YoY moves for Non Operating Income: up 175.51% in 2022, down 340.28% in 2022.
  • Xeris Biopharma Holdings' Non Operating Income stood at -$2.5 million in 2021, then soared by 175.51% to $1.9 million in 2022, then tumbled by 299.0% to -$3.8 million in 2023, then plummeted by 79.45% to -$6.8 million in 2024, then increased by 16.2% to -$5.7 million in 2025.
  • The last three reported values for Non Operating Income were -$5.7 million (Q4 2025), -$6.1 million (Q3 2025), and -$6.4 million (Q2 2025) per Business Quant data.